Trade Humana - HUM CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.98 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.030779% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.013666% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Humana Inc ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Prev. Close* | 498.97 |
Open* | 492.43 |
1-Year Change* | 31.05% |
Day's Range* | 480.08 - 494.96 |
52 wk Range | 378.91-571.30 |
Average Volume (10 days) | 1.01M |
Average Volume (3 months) | 21.13M |
Market Cap | 60.98B |
P/E Ratio | 21.85 |
Shares Outstanding | 126.60M |
Revenue | 91.49B |
EPS | 22.05 |
Dividend (Yield %) | 0.65395 |
Beta | 0.71 |
Next Earnings Date | Feb 1, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jan 27, 2023 | 480.97 | -12.77 | -2.59% | 493.74 | 496.38 | 479.13 |
Jan 26, 2023 | 498.97 | 0.90 | 0.18% | 498.07 | 504.80 | 497.56 |
Jan 25, 2023 | 501.66 | 6.90 | 1.39% | 494.76 | 511.70 | 491.05 |
Jan 24, 2023 | 499.77 | 8.87 | 1.81% | 490.90 | 502.02 | 489.61 |
Jan 23, 2023 | 493.75 | 0.24 | 0.05% | 493.51 | 500.37 | 491.34 |
Jan 20, 2023 | 496.52 | 5.64 | 1.15% | 490.88 | 497.11 | 487.74 |
Jan 19, 2023 | 491.15 | 8.49 | 1.76% | 482.66 | 496.49 | 482.65 |
Jan 18, 2023 | 484.31 | 0.28 | 0.06% | 484.03 | 493.45 | 483.03 |
Jan 17, 2023 | 489.97 | 2.67 | 0.55% | 487.30 | 493.99 | 487.11 |
Jan 13, 2023 | 490.76 | -2.16 | -0.44% | 492.92 | 504.56 | 487.88 |
Jan 12, 2023 | 493.72 | 2.94 | 0.60% | 490.78 | 495.39 | 481.16 |
Jan 11, 2023 | 492.09 | 13.32 | 2.78% | 478.77 | 492.76 | 478.77 |
Jan 10, 2023 | 480.89 | 2.09 | 0.44% | 478.80 | 485.21 | 477.87 |
Jan 9, 2023 | 481.36 | -12.37 | -2.51% | 493.73 | 499.32 | 479.01 |
Jan 6, 2023 | 492.19 | 4.08 | 0.84% | 488.11 | 494.29 | 484.34 |
Jan 5, 2023 | 487.26 | -2.52 | -0.51% | 489.78 | 493.06 | 481.39 |
Jan 4, 2023 | 491.57 | -5.29 | -1.06% | 496.86 | 500.69 | 484.15 |
Jan 3, 2023 | 499.94 | -4.76 | -0.94% | 504.70 | 508.29 | 489.12 |
Dec 30, 2022 | 511.69 | 5.16 | 1.02% | 506.53 | 513.28 | 506.39 |
Dec 29, 2022 | 512.53 | 0.41 | 0.08% | 512.12 | 516.66 | 511.68 |
Humana Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 54379 | 53767 | 56912 | 64888 | 77155 | 83064 |
Total Operating Expense | 52638 | 49505 | 54598 | 61696 | 72169 | 79916 |
Depreciation / Amortization | 354 | 378 | 405 | 458 | 489 | 596 |
Unusual Expense (Income) | 0 | -936 | 786 | 0 | 0 | 128 |
Other Operating Expenses, Total | 7277 | 6567 | 7525 | 7145 | 10052 | 9993 |
Operating Income | 1741 | 4262 | 2314 | 3192 | 4986 | 3148 |
Interest Income (Expense), Net Non-Operating | -189 | -242 | -218 | -242 | -283 | -326 |
Net Income Before Taxes | 1552 | 4020 | 2063 | 3456 | 4600 | 3354 |
Net Income After Taxes | 614 | 2581 | 1711 | 2693 | 3293 | 2869 |
Net Income Before Extra. Items | 614 | 2581 | 1722 | 2707 | 3367 | 2933 |
Net Income | 614 | 2448 | 1683 | 2707 | 3367 | 2933 |
Income Available to Common Excl. Extra. Items | 614 | 2581 | 1722 | 2707 | 3367 | 2933 |
Income Available to Common Incl. Extra. Items | 614 | 2448 | 1683 | 2707 | 3367 | 2933 |
Diluted Net Income | 614 | 2448 | 1683 | 2707 | 3367 | 2933 |
Diluted Weighted Average Shares | 150.917 | 145.585 | 138.403 | 134.727 | 133.012 | 129.396 |
Diluted EPS Excluding Extraordinary Items | 4.06846 | 17.7285 | 12.4419 | 20.0925 | 25.3135 | 22.6668 |
Dividends per Share - Common Stock Primary Issue | 1.16 | 1.49 | 1.9 | 2.15 | 3.05 | 2.8 |
Diluted Normalized EPS | 4.06846 | 13.6006 | 17.152 | 20.0925 | 25.3135 | 23.513 |
Total Premiums Earned | 53990 | 53362 | 56398 | 64387 | 76001 | 82877 |
Net Investment Income | 389 | 405 | 514 | 501 | 1154 | 187 |
Losses, Benefits, and Adjustments, Total | 45007 | 43496 | 45882 | 53857 | 61628 | 69199 |
Total Extraordinary Items | -133 | -39 | 0 | |||
Other, Net | -33 | 506 | -103 | 532 | ||
Equity In Affiliates | 11 | 14 | 74 | 65 | ||
Selling/General/Admin. Expenses, Total | 236 | |||||
Minority Interest | -1 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 20668 | 20645 | 20697 | 21054 | 23970 |
Total Operating Expense | 19445 | 19409 | 20069 | 20993 | 22681 |
Depreciation / Amortization | 142 | 144 | 150 | 160 | 170 |
Other Operating Expenses, Total | 2007 | 2094 | 2532 | 3360 | 2869 |
Operating Income | 1223 | 1236 | 628 | 61 | 1289 |
Interest Income (Expense), Net Non-Operating | -68 | -79 | -88 | -91 | -90 |
Other, Net | -115 | -419 | 1096 | -30 | 21 |
Net Income Before Taxes | 1040 | 738 | 1636 | -60 | 1220 |
Net Income After Taxes | 807 | 555 | 1516 | -9 | 934 |
Equity In Affiliates | 21 | 33 | 15 | -4 | -4 |
Net Income Before Extra. Items | 828 | 588 | 1531 | -14 | 930 |
Net Income | 828 | 588 | 1531 | -14 | 930 |
Income Available to Common Excl. Extra. Items | 828 | 588 | 1531 | -14 | 930 |
Income Available to Common Incl. Extra. Items | 828 | 588 | 1531 | -14 | 930 |
Diluted Net Income | 828 | 588 | 1531 | -14 | 930 |
Diluted Weighted Average Shares | 129.551 | 129.387 | 129.255 | 128.61 | 127.474 |
Diluted EPS Excluding Extraordinary Items | 6.39131 | 4.54451 | 11.8448 | -0.10886 | 7.29561 |
Dividends per Share - Common Stock Primary Issue | 0.7 | 0.7 | 0.7 | 0.7 | 0.7875 |
Diluted Normalized EPS | 6.39131 | 4.67238 | 12.3538 | 0.06804 | 7.3977 |
Total Premiums Earned | 20590 | 20469 | 20730 | 21088 | 23967 |
Net Investment Income | 78 | 176 | -33 | -34 | 3 |
Losses, Benefits, and Adjustments, Total | 17296 | 17149 | 17316 | 17438 | 19625 |
Unusual Expense (Income) | 22 | 71 | 35 | 17 | |
Minority Interest | 0 | -1 | 0 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash & Equivalents | 3877 | 4042 | 2343 | 4054 | 4673 | 3394 |
Total Assets | 25396 | 27178 | 25413 | 29074 | 34969 | 44358 |
Property/Plant/Equipment, Total - Net | 1505 | 1584 | 1735 | 2365 | 2808 | 3751 |
Property/Plant/Equipment, Total - Gross | 3195 | 3560 | 4048 | 5025 | 5931 | 6625 |
Accumulated Depreciation, Total | -1690 | -1976 | -2313 | -2660 | -3123 | -2874 |
Goodwill, Net | 3272 | 3281 | 3897 | 3928 | 4447 | 11092 |
Intangibles, Net | 280 | 226 | 245 | 177 | 329 | 2639 |
Long Term Investments | 9798 | 12302 | 11484 | 12441 | 14936 | 14113 |
Other Assets, Total | 5384 | 4889 | 4694 | 5053 | 6638 | 7555 |
Payable/Accrued | 2467 | 4069 | 3067 | 3638 | 3884 | 4324 |
Notes Payable/Short Term Debt | 212 | 141 | 1466 | 525 | 320 | 326 |
Current Port. of LT Debt/Capital Leases | 300 | 150 | 399 | 399 | 600 | 1953 |
Other Current Liabilities, Total | 280 | 378 | 283 | 247 | 318 | 254 |
Total Liabilities | 14711 | 17336 | 15252 | 17037 | 21241 | 28278 |
Total Long Term Debt | 3792 | 4770 | 4375 | 4967 | 6060 | 10541 |
Long Term Debt | 3792 | 4770 | 4375 | 4967 | 6060 | 10541 |
Other Liabilities, Total | 3097 | 3160 | 800 | 809 | 1432 | 1837 |
Total Equity | 10685 | 9842 | 10161 | 12037 | 13728 | 16080 |
Common Stock | 33 | 33 | 33 | 33 | 33 | 33 |
Additional Paid-In Capital | 2562 | 2445 | 2535 | 2820 | 2705 | 3082 |
Retained Earnings (Accumulated Deficit) | 11454 | 13670 | 15072 | 17483 | 20517 | 23086 |
Treasury Stock - Common | -3298 | -6325 | -7320 | -8455 | -9918 | -10163 |
Other Equity, Total | -66 | 19 | -159 | 156 | 391 | 42 |
Total Liabilities & Shareholders’ Equity | 25396 | 27178 | 25413 | 29074 | 34969 | 44358 |
Total Common Shares Outstanding | 149.305 | 137.679 | 135.567 | 132.105 | 128.861 | 128.802 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | |
Accrued Expenses | 448 | 484 | 731 | |||
Minority Interest | 23 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Cash & Equivalents | 3877 | 3378 | 4304 | 3394 | 4864 |
Total Assets | 37415 | 38070 | 45320 | 44358 | 46308 |
Property/Plant/Equipment, Total - Net | 2507 | 2690 | 2898 | 3073 | 3189 |
Goodwill, Net | 4602 | 4914 | 10806 | 11092 | 11139 |
Intangibles, Net | 343 | 342 | 2658 | 2639 | 2651 |
Long Term Investments | 15576 | 15893 | 14957 | 14113 | 13622 |
Other Assets, Total | 8314 | 8415 | 7818 | 8233 | 7669 |
Payable/Accrued | 4777 | 4898 | 4957 | 4509 | 5859 |
Notes Payable/Short Term Debt | 1547 | 1345 | 240 | 326 | 2007 |
Other Current Liabilities, Total | 325 | 323 | 277 | 254 | 288 |
Total Liabilities | 23225 | 23227 | 29060 | 28278 | 30989 |
Total Long Term Debt | 6062 | 6063 | 11466 | 10541 | 11285 |
Long Term Debt | 6062 | 6063 | 11466 | 10541 | 11285 |
Other Liabilities, Total | 1863 | 2113 | 2545 | 2383 | 2149 |
Total Equity | 14190 | 14843 | 16260 | 16080 | 15319 |
Common Stock | 33 | 33 | 33 | 33 | 33 |
Additional Paid-In Capital | 2712 | 3018 | 3064 | 3082 | 3103 |
Retained Earnings (Accumulated Deficit) | 21252 | 21751 | 23191 | 23086 | 23915 |
Treasury Stock - Common | -9915 | -10175 | -10173 | -10163 | -11160 |
Other Equity, Total | 108 | 216 | 145 | 42 | -572 |
Total Liabilities & Shareholders’ Equity | 37415 | 38070 | 45320 | 44358 | 46308 |
Total Common Shares Outstanding | 129.014 | 128.505 | 128.534 | 128.802 | 126.493 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Current Port. of LT Debt/Capital Leases | 795 | 1953 | |||
Minority Interest | 22 | 23 | 23 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 614 | 2448 | 1683 | 2707 | 3367 | 2934 |
Cash From Operating Activities | 1936 | 4051 | 2173 | 5284 | 5639 | 2262 |
Cash From Operating Activities | 388 | 410 | 444 | 505 | 528 | 640 |
Amortization | 77 | 75 | 90 | 70 | 88 | 73 |
Deferred Taxes | -71 | 132 | 194 | 162 | 195 | 15 |
Non-Cash Items | 154 | 177 | 948 | 149 | 107 | -1014 |
Cash Taxes Paid | 916 | 1498 | 631 | 518 | 1132 | 227 |
Cash Interest Paid | 185 | 216 | 195 | 212 | 258 | 285 |
Changes in Working Capital | 774 | 809 | -1186 | 1691 | 1354 | -386 |
Cash From Investing Activities | -1362 | -2941 | -3087 | -1278 | -3065 | -6556 |
Capital Expenditures | -527 | -526 | -612 | -736 | -964 | -1316 |
Other Investing Cash Flow Items, Total | -835 | -2415 | -2475 | -542 | -2101 | -5240 |
Cash From Financing Activities | 732 | -945 | -785 | -2295 | -1955 | 3015 |
Financing Cash Flow Items | 1093 | 1823 | -640 | -623 | -939 | -337 |
Total Cash Dividends Paid | -177 | -220 | -265 | -291 | -323 | -354 |
Issuance (Retirement) of Stock, Net | -93 | -3303 | -1045 | -1012 | -1771 | -58 |
Issuance (Retirement) of Debt, Net | -91 | 755 | 1165 | -369 | 1078 | 3764 |
Net Change in Cash | 1306 | 165 | -1699 | 1711 | 619 | -1279 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 828 | 1416 | 2947 | 2934 | 930 |
Cash From Operating Activities | -837 | -477 | 2358 | 2262 | 302 |
Cash From Operating Activities | 153 | 308 | 468 | 640 | 181 |
Amortization | 15 | 30 | 51 | 73 | 24 |
Non-Cash Items | 18 | 30 | -1066 | -1014 | 47 |
Cash Taxes Paid | -1 | 386 | 183 | 227 | -20 |
Cash Interest Paid | 40 | 132 | 219 | 285 | 67 |
Changes in Working Capital | -1851 | -2261 | -42 | -386 | -880 |
Cash From Investing Activities | -1488 | -2203 | -6454 | -6556 | -648 |
Capital Expenditures | -290 | -619 | -945 | -1316 | -295 |
Other Investing Cash Flow Items, Total | -1198 | -1584 | -5509 | -5240 | -353 |
Cash From Financing Activities | 1529 | 1385 | 3727 | 3015 | 1816 |
Financing Cash Flow Items | 1015 | 1162 | 576 | -337 | 2474 |
Total Cash Dividends Paid | -83 | -173 | -263 | -354 | -91 |
Issuance (Retirement) of Stock, Net | -29 | -28 | -33 | -58 | -1037 |
Issuance (Retirement) of Debt, Net | 626 | 424 | 3447 | 3764 | 470 |
Net Change in Cash | -796 | -1295 | -369 | -1279 | 1470 |
Deferred Taxes | 0 | 0 | 15 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.787 | 11124317 | 148717 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 7.0898 | 8975686 | -420829 | 2022-09-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 5.2347 | 6627148 | -945303 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 4.9267 | 6237200 | 157810 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.5883 | 5808741 | -37684 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.4341 | 5613554 | 53899 | 2022-09-30 | LOW |
Capital International Investors | Investment Advisor | 2.6367 | 3338129 | -21752 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 2.2422 | 2838670 | -1051470 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7124 | 2167946 | 69266 | 2022-09-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.3663 | 1729799 | -636428 | 2022-09-30 | LOW |
Capital World Investors | Investment Advisor | 1.3578 | 1718981 | 88 | 2022-09-30 | LOW |
Newport Trust Company | Bank and Trust | 1.0683 | 1352443 | -14735 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9597 | 1214923 | -51604 | 2021-12-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 0.9077 | 1149177 | 40419 | 2022-09-30 | HIGH |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.8942 | 1132014 | 229173 | 2022-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.8894 | 1126002 | 5926 | 2022-09-30 | LOW |
BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 0.8796 | 1113580 | -339668 | 2022-09-30 | LOW |
Boston Partners | Investment Advisor/Hedge Fund | 0.8071 | 1021733 | 24003 | 2022-09-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7935 | 1004622 | -53005 | 2022-09-30 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 0.775 | 981147 | -12780 | 2022-09-30 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Humana Company profile
About Humana Inc
Humana Inc. is a health and well-being company. The Company operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. It also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Humana Inc revenues increased 8% to $83.06B. Net income decreased 13% to $2.93B. Revenues reflect Retail segment increase of 10% to $73.84B, Healthcare Services segment increase from $1.02B to $2.22B, Medical Expense Ratio -%-Employer Group decrease of 4% to 82.5%. Net income was offset by Eliminations/Corporate segment loss totaling $202M vs. income of $1.24B.
Equity composition
Common Stock $.16 2/3 Par, 3/11, 300M auth., 191,607,107 issd., less 23,212,730 shs. in Treas. @ $583.3M. Insiders owns approx. 0.57%. PO11/82, 3M shares @ $13.125 by Lehman Brothers Kuhn Loeb. *NOTE: 3/93, the acute care hospital division (Galen Health Care) was spun off. FY'99-'00 and FY'00-'01 Q's are reclassified.
Industry: | Managed Healthcare (NEC) |
500 W Main St
LOUISVILLE
KENTUCKY 40202
US
Income Statement
- Annual
- Quarterly
News

FX Weekly Outlook: USD, GBP/USD, EUR/USD Analysis
USD, GBP/USD, EUR/USD forecasts for the week ahead.
16:33, 27 January 2023
WTI, Gold, Silver – commodities weekly forecast for the week ahead
Strength to strength in the commodity space, however, topside exhaustion begins to creep in
13:53, 27 January 2023
S&P 500, Nasdaq, DAX 40, Hang Seng technical update
Can the S&P 500 hold above its 2022 descending trend line?
12:44, 26 January 2023
Amazon Q4 earnings: online retailer to feel the pinch of higher costs and slowing consumer spending
AMZN Q4 earnings preview and technical analysis
09:59, 25 January 2023
Canadian Dollar Forecast: Bank of Canada Heading Towards a Final Rate Hike
Bank of Canada expected to hike 25bps at its upcoming meeting. Focus on whether the BoC announces a pause going forward.
15:49, 24 January 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com